Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation as a Therapeutic Intervention to Improve Cancer Related Fatigue and Weakness

NCT07159100 is registered in ClinicalTrials.gov with Kessler Foundation as lead sponsor.

NCT NCT07159100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07159100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation as a Therapeutic Intervention to Improve Cancer Related Fatigue and Weakness
Lead sponsor
Kessler Foundation
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 10, 2025
Completion date
December 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related fatigue, neuromodulation